Doctor profile · Federal record

Dr. Lindsay Orris, D.O.

Internal Medicine Physician (CMS: Rheumatology) · Bettendorf, IA

  • NPI 1225263833
  • Accepts Medicare
  • MIPS 66.5 / 100 · 2023
  • 17 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2979 Victoria St
Bettendorf, IA 527222784
(563) 359-4440
fax (563) 359-4644
Mailing address
Po Box 4709
Davenport, IA 528084709

Credentials & registration

NPPES · NUCC
NPI registered
May 2009 — 17 yrs on file
Profile last updated
August 28, 2020
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
207R00000X — NUCC code
State license (1)
Iowa #4321
Medicaid
IA #1303261

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1225263833. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
69,658
Distinct HCPCS
10
Medicare allowed
$1,009,107
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 26,000 13 $5
J1602 Injection, golimumab, 1 mg, for intravenous use 13,011 25 $13
J3111 Injection, romosozumab-aqqg, 1 mg 9,870 13 $10
J3262 Injection, tocilizumab, 1 mg 7,400 11 $6
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 2,525 13 $42
J0897 Injection, denosumab, 1 mg 2,400 27 $23
J9312 Injection, rituximab, 10 mg 2,350 12 $80
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,320 18 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 427 259 $119
96372 Injection of drug or substance under skin or into muscle 285 60 $13

In context: peer comparison

Among 1 peers in Bettendorf Internal Medicine Physician, average services per provider: 1,547. This provider delivers 45× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$864
Transactions
35
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 7 $164.05
Novartis Pharmaceuticals Corporation 2 $154.13
Abbvie INC. 5 $121.57
Amgen INC. 4 $68.91
Boehringer Ingelheim Pharmaceuticals, INC. 3 $67.23
Ucb, INC. 3 $60.07
Radius Health, INC. 2 $41.39
Genentech USA, INC. 2 $29.24
Teva Pharmaceuticals USA, INC. 1 $22.75
Organon LLC 1 $20.36
AstraZeneca Pharmaceuticals Lp 1 $20.18
Genzyme Corporation 1 $19.51
Lilly USA, LLC 1 $17.95
GlaxoSmithKline, LLC. 1 $15.64
Pfizer INC. 1 $13.84

By nature of payment

Food and Beverage
$784
Education
$80

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,643
Patients
761
Total drug cost
$104,371
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 541 158 $45,108
Prednisone Generic 506 163 $5,298
Methotrexate (Methotrexate Sodium) Brand 357 100 $14,888
Leflunomide Generic 227 61 $18,322
Meloxicam Generic 168 54 $993
Tramadol Hcl Generic 136 37 $1,429
Gabapentin Generic 112 28 $4,208
Celecoxib Generic 104 30 $4,094
Allopurinol Generic 101 27 $1,928
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 74 11 $2,382

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Lindsay Orris's medical specialty?
Dr. Lindsay Orris practices Internal Medicine Physician in Bettendorf, IA.
Where does Dr. Lindsay Orris practice?
Dr. Lindsay Orris practices at 2979 Victoria St, Bettendorf, IA 527222784. Office phone: 5633594440.
What is Dr. Lindsay Orris's NPI?
Dr. Lindsay Orris's National Provider Identifier (NPI) is 1225263833, issued by NPPES.
Does Dr. Lindsay Orris accept Medicare assignment?
Yes. Dr. Lindsay Orris accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lindsay Orris commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111). Source: CMS Medicare Physician & Other Practitioners file.